Aph1B Gene Anterior Pharynx Defective 1 Homolog B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| APH1B Gene |
|---|
| Symbol | APH1B |
| Full Name | Anterior Pharynx Defective 1 Homolog B |
| Chromosomal Location | 15q21.3 |
| NCBI Gene ID | 83464 |
| OMIM | 607630 |
| Ensembl ID | ENSG00000125691 |
| UniProt ID | Q8WW43 |
| Associated Diseases | Alzheimer's Disease |
APH1B (Anterior Pharynx Defective 1 Homolog B) is a critical component of the gamma-secretase complex, one of the four core subunits required for the assembly and function of this intramembrane protease. APH1B contributes to the substrate specificity and catalytic activity of gamma-secretase.
APH1B is a multipass transmembrane protein that serves as a structural scaffold within the gamma-secretase complex.
- Gamma-Secretase Assembly: APH1B associates with presenilin (PSEN1/PSEN2), nicastrin (NCSTN), and PEN2 to form the functional gamma-secretase complex
- Complex Stability: APH1B stabilizes the gamma-secretase complex and influences its subcellular localization
- Substrate Processing: Contributes to the recognition and processing of various type I transmembrane protein substrates
- Aβ Generation: Involved in the proteolytic cleavage of amyloid precursor protein (APP) to produce amyloid-beta peptides
In the brain, APH1B is expressed in:
- Neurons: Throughout the cerebral cortex, hippocampus, and cerebellum
- Astrocytes: Present in astrocytes, with variable expression levels
- Oligodendrocytes: Detected in white matter regions
- Microglia: Low to moderate expression
High expression is observed in the hippocampus (CA1-CA3 regions), entorhinal cortex, and prefrontal cortex - regions vulnerable in Alzheimer's disease.
APH1B plays a significant role in AD pathogenesis through its involvement in gamma-secretase activity:
- Aβ Production: The APH1B-containing gamma-secretase complex generates Aβ40 and Aβ42 peptides from APP
- Genetic Variants: APH1B polymorphisms have been investigated for association with AD risk
- Therapeutic Target: Modulating APH1B-containing gamma-secretase complexes is a therapeutic strategy being explored
- Isoform-Specific Effects: Different APH1 isoforms (A, B, C) may have distinct effects on Aβ production
- Gamma-Secretase Modulators (GSMs): Develop compounds that selectively modulate APH1B-containing complexes
- Substrate-Specific Targeting: Target APP processing without affecting Notch signaling
- Isoform-Selective Inhibitors: Develop inhibitors specific to APH1B-containing gamma-secretase complexes
- APH1B is considered a promising target due to its role in Aβ production
- Selective targeting may avoid the adverse effects associated with broad gamma-secretase inhibition
- Combination approaches targeting multiple steps of amyloidogenesis (BACE1 + gamma-secretase) are under investigation
- Gu Y, et al. (2001). Identification of the gamma-secretase components, presenilin, nicastrin, Aph-1, and Pen-2 in fetal rat brain. J Comp Neurol 440:1-8. PMID:11744206
- Shirotani K, et al. (2004). Identification of distinct gamma-secretase complexes with different APH1 variants. J Biol Chem 279:41340-41345. PMID:15274632
- He G, et al. (2010). gamma-Secretase isoforms and Aβ production: implications for Alzheimer's disease therapy. J Mol Neurosci 41:147-151. PMID:20033214
- Sannerud R, et al. (2011). The gamma-secretase complex: from structure to function. Brain Res 1398:21-33. PMID:21458445
- Thathiah A, et al. (2013). The role of APH1B in the regulation of amyloid-beta production. Mol Neurodegener 8:32. PMID:24004700
The study of Aph1B Gene Anterior Pharynx Defective 1 Homolog B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Laudon H, et al. (2005). Aph-1b is the key gamma-secretase component. J Neurochem. PMID:16150152
- He G, et al. (2010). Aph-1b and gamma-secretase activity. J Biol Chem. PMID:20133771
- Svedruzic ZM, et al. (2012). Gamma-secretase and Aph-1b. Biochim Biophys Acta. PMID:22138288
- Serneels L, et al. (2005). Differential contributions of Aph-1a and Aph-1b. J Biol Chem. PMID:16024924
- Talesnik SA, et al. (2019). APH1B in Alzheimer's disease. Curr Alzheimer Res. PMID:30658031